This topic contains a solution. Click here to go to the answer

Author Question: Relative to a perfectly competitive market, as long as the monopolist does not benefit from ... (Read 106 times)

melina_rosy

  • Hero Member
  • *****
  • Posts: 531
Relative to a perfectly competitive market, as long as the monopolist does not benefit from substantial economies of scale,
 a. price and quantity are higher under monopoly
  b. price and quantity are lower under monopoly
  c. quantity is higher and price is lower under monopoly
  d. quantity is lower and price is higher under monopoly
  e. there are no differences in price and quantity

Question 2

What act of Congress declared restraint of trade illegal and declared any attempt at monopolizing unlawful?
 a. the Celler-Kefauver Anti-Merger Act
  b. the Sherman Antitrust Act
  c. the Clayton Act
  d. the Wheeler-Lea Act
  e. the Clayton-Celler Act



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lauravaras

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

D

Answer to Question 2

B





 

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library